GlassScriptPhysician profile
Spenser Morton
NPI 1376923144
$3,992.83
in general payments reported to CMS, 2019-2025
16 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.67 · 2020: $54.87 · 2021: $653 · 2022: $290 · 2023: $1,093 · 2024: $1,223 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,565 · Travel and Lodging: $304 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,565.32 |
| Travel and Lodging | $303.73 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,712.53 | 2019-2025 | Clareon, Centurion, Argos |
| Glaukos Corporation | $336.80 | 2020-2024 | Istent Trabecular Micro-Bypass System Model Is3, Ce-Marked Kxla System |
| Abbvie INC. | $302.68 | 2023-2025 | |
| Sight Sciences, INC. | $264.02 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ocular Therapeutix, INC. | $228.04 | 2021-2024 | Dextenza |
| Bausch & Lomb Americas INC. | $207.46 | 2024-2025 | Xiidra, Envista Mx60 Iol, Miebo |
| Mallinckrodt Hospital Products INC. | $159.78 | 2020-2023 | Acthar |
| Rayner Intraocular Lenses Limited | $138.62 | 2024-2025 | Omidria, Rayone Aspheric, Rayone Emv |
| Rxsight INC | $137.76 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Harrow Eye, LLC | $132.29 | 2023-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $101.31 | 2020-2025 | |
| Dompe US, INC. | $77.34 | 2021-2025 | Oxervate |
| Allergan, INC. | $69.55 | 2021-2022 | |
| New World Medical,INC. | $57.65 | 2023 | |
| Biotissue Holdings INC. | $45.86 | 2022-2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $21.14 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spenser Morton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.